|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K 14/48 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3099713 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15701985.2 |
| Date of filing the European patent application | 2015-02-02 | |
| (97) | Date of publication of the European application | 2016-12-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-15 |
| (46) | Date of publication of the claims translation | 2020-07-10 |
| (86) | Number | PCT/EP2015/052098 |
| Date | 2015-02-02 |
| (87) | Number | WO 2015/114150 |
| Date | 2015-08-06 |
| (30) | Number | Date | Country code |
| 201461934828 P | 2014-02-02 | US |
| (72) |
SCHOFIELD, Darren, GB
SLEEMAN, Matthew Alexander, GB
CHESSELL, Iain Patrick, GB
HATCHER, Jonathan, GB
LOWE, David, GB
|
| (73) |
MedImmune Limited,
Milstein Building Granta Park, Cambridge Cambridgeshire CB21 6GH,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Chimerinis baltymas, sudarytas iš NGF antagonistinio domeno ir TNFA antagonistinio domeno |
| CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND A TNFA ANTAGONIST DOMAIN |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 12 | 289.00 EUR |
| 2027-02-02 |